Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASC16 + danoprevir/ritonavir ± ribavirin in genotype 1 chronic HCV
CTR20181645Phase 3Active
- Sponsor
- Ascletis Pharma Inc.
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ravidasvir in hepatitis C virus infection, sponsored by Ascletis Pharma Inc.. Started Sep 2018; status: active.
02
Drugs
ravidasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20181645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181645.